Pediatric Cancer

Debra Friedman, MD, director of the Division of Pediatric Hematology/Oncology, has been awarded a $100,000 Hyundai Hope on Wheels Impact Award. The grant was celebrated in a “handprint ceremony” with Hyundai representatives on June 12. Read More

An inhibitor of cell metabolism may be a good therapeutic target for neuroblastoma, which accounts for about 15 percent of pediatric cancer-related deaths. Read More

Richard Ho, M.D., MSCI, associate professor of Pediatrics in the Division of Pediatric Hematology/Oncology, has been awarded a $250,000 Hyundai Hope On Wheels Scholar Grant to study ways to reduce long-term side effects of chemotherapy in pediatric cancer survivors and develop more personalized therapies for pediatric oncology patients. Read More

William Tansey, Ph.D., professor of Cell Development and Biology and Ingram Professor of Cancer Research, has been awarded a two-year, $250,000 grant from Alex’s Lemonade Stand Foundation (ALSF) to study malignant rhabdoid tumors (MRTs). Read More

Debra Friedman, M.D., director of Pediatric Hematology/Oncology and E. Bronson Ingram Professor of Pediatric Oncology, has received a $50,000 Hyundai Hope On Wheels Impact grant recently for her track record in providing excellent patient care to families affected by pediatric cancer and to support a pediatric cancer program aimed at developing innovative therapies. Read More

Terrah Foster Akard, Ph.D., M.S.N., R.N. The Vanderbilt University School of Nursing (VUSN) has been awarded a $1.8 million grant by National Institute of Health/National Institute of Nursing Research. The four-year grant is in partnership with the Palliative Care Research Cooperative (PCRC), and will recruit children with… Read More